Atlas Trials

A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

Clinical trial NCT05339802 · UNKNOWN

Trial details

NCT number
NCT05339802
Sponsor
Mabwell (Shanghai) Bioscience Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Skin Infection
Start date
2022-02-16
Primary completion
2023-10-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.